Primary isolated amyloidosis in the extraocular muscle as a rare cause of ophthalmoplegia: A case report and literature review.

Diplopia External ophthalmoplegia Extraocular muscle biopsy Extraocular muscle enlargement Orbital amyloidosis

Journal

American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 31 08 2020
revised: 01 11 2020
accepted: 21 02 2021
entrez: 18 3 2021
pubmed: 19 3 2021
medline: 19 3 2021
Statut: epublish

Résumé

To report a case of external ophthalmoplegia due to an uncommon form of amyloidosis exclusively affecting the lateral rectus muscle, and to discuss the clinical manifestation, diagnostic challenges, and management pitfalls of isolated amyloidosis in the extraocular muscle. A 64-year-old woman presented with diplopia in her left gaze lasting for six months. She had orthophoria in the primary position and abduction limitation in the left eye. Routine laboratory examinations were unremarkable. Orbital magnetic resonance imaging showed fusiform enlargement of the left lateral rectus muscle, without tendon involvement. Extraocular muscle biopsy was recommended to make a diagnosis, which revealed amyloid deposition in the lateral rectus muscle. A systemic work-up showed no evidence of systemic amyloidosis. Therefore, a diagnosis of primary isolated amyloidosis was made. Orthophoria in the primary position and diplopia in the lateral gaze persisted at the six-month follow-up. Atypical extraocular muscle enlargement should alert clinicians to the need for tissue biopsy to identify uncommon etiologies, such as amyloidosis. There are no pathognomonic or radiological features to distinguish localized from systemic amyloidosis. Therefore, if amyloidosis of the extraocular muscles is diagnosed, a systemic work-up is needed to rule out systemic amyloidosis, which is potentially life-threatening.

Identifiants

pubmed: 33732950
doi: 10.1016/j.ajoc.2021.101052
pii: S2451-9936(21)00043-8
pmc: PMC7937664
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101052

Informations de copyright

© 2021 Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The following authors have no financial disclosures: NN, YK, AK, YK, HT, and YY.

Références

Br J Ophthalmol. 1996 Nov;80(11):1013-7
pubmed: 8976732
Ophthalmology. 2006 Sep;113(9):1657-64
pubmed: 16828514
J AAPOS. 2020 Apr;24(2):122-124
pubmed: 32087324
Einstein (Sao Paulo). 2016 Oct-Dec;14(4):553-556
pubmed: 28076605
Orbit. 2008;27(6):432-7
pubmed: 19085298
Br J Ophthalmol. 2018 Nov;102(11):1586-1590
pubmed: 29352070
N Engl J Med. 2003 Aug 7;349(6):583-96
pubmed: 12904524
Br J Ophthalmol. 1987 Jan;71(1):32-3
pubmed: 3814569
Arch Ophthalmol. 1989 Oct;107(10):1428-9
pubmed: 2803085
Amyloid. 2004 Sep;11(3):179-83
pubmed: 15523920
Ophthalmologica. 1980;181(1):31-40
pubmed: 7207971
Ophthalmic Plast Reconstr Surg. 2010 Sep-Oct;26(5):315-22
pubmed: 20592641
J AAPOS. 2020 Feb;24(1):48-51.e1
pubmed: 31830573
AJNR Am J Neuroradiol. 1998 Oct;19(9):1799-801
pubmed: 9802509
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):395-6
pubmed: 22119881
J Neuroophthalmol. 2016 Jun;36(2):167-73
pubmed: 26967574
Surv Ophthalmol. 1999 Nov-Dec;44(3):187-213
pubmed: 10588439
Orbit. 1999 Jun;18(2):105-106
pubmed: 12045993
Int Ophthalmol. 2016 Apr;36(2):281-98
pubmed: 26466598
Singapore Med J. 2006 Jan;47(1):65-7
pubmed: 16397724

Auteurs

Noriko Nishikawa (N)

Department of Ophthalmology, Asahikawa Medical University, 2-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, 078-8510, Japan.

Yuriya Kawaguchi (Y)

Department of Ophthalmology, Asahikawa Medical University, 2-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, 078-8510, Japan.

Ami Konno (A)

Department of Ophthalmology, Asahikawa Medical University, 2-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, 078-8510, Japan.

Yuya Kitani (Y)

Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical University, 2-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, 078-8510, Japan.

Hidehiro Takei (H)

Department of Diagnostic Pathology, Asahikawa Medical University, 2-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, 078-8510, Japan.

Yasuo Yanagi (Y)

Department of Ophthalmology, Asahikawa Medical University, 2-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
Singapore National Eye Centre, Singapore Eye Research Institute, 11 Third Hospital Ave, 168751, Singapore.

Classifications MeSH